Augmented Interoceptive Exposure Training in Anorexia Nervosa

NAActive, not recruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

August 31, 2021

Study Completion Date

November 30, 2024

Conditions
Anorexia Nervosa
Interventions
DRUG

Isoproterenol

The goal of this experiment is to use isoproterenol in the context of inhibitory fear learning to reduce eating-related anxiety in AN, and to explore whether these changes are related to interoceptive awareness and autonomic reactivity.

OTHER

placebo

placebo

Trial Locations (1)

74136

Laureate Institute for Brain Research, Tulsa

All Listed Sponsors
collaborator

Brain & Behavior Research Foundation

OTHER

lead

Laureate Institute for Brain Research, Inc.

OTHER